Cat. No.: DAB-0011759
Product Information | |
---|---|
Clonality | Monoclonal |
Isotype | IgG2a |
Host Species | Mouse |
Reactivity | Human, Mouse, Rat, Monkey |
Applications | WB, IP |
Product Description | Monoclonal antibody is produced by immunizing animals with a recombinant human ApoA4 protein. |
Format | Liquid |
Purity | Affinity purity |
Target Information | |
---|---|
Target Name | APOA4 |
UniProt No. | P06727 |
Gene ID | 337 |
Gene Description | Apolipoproteins are plasma lipoproteins that function as transporters of lipids and cholesterol in the circulatory system. Chylomicrons are a fundamental class of apolipoproteins containing very low-density lipoproteins, intermediate-density lipoproteins, low-density lipoproteins, and high-density lipoproteins .Apolipoprotein A-IV is a glycoprotein that exists as a free apolipoprotein in human plasma. ApoA4 activates the lecithin cholesterol acyl transferase to modulate the rate of lipid transfer protein activity. Additional evidence suggests that ApoA4 may also act as an antioxidant to inhibit LDL oxidation in the atherosclerosis model. |
Shipping & Storage | |
---|---|
Shipping | Shipped at 4 °C. |
Storage Instructions | Store at –20 °C. Do not aliquot the antibody. |
Storage Buffer | Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.